McGovern D, Jones R, Jayne D, Smith R
Drugs. 2025; 85(3):325-341.
PMID: 39969779
DOI: 10.1007/s40265-024-02143-z.
Schulz L, Varghese A, Michenkova M, Wedemeyer M, Pindrik J, Leonard J
Pediatr Res. 2024; .
PMID: 39725707
DOI: 10.1038/s41390-024-03733-z.
Alic L, Dendinovic K, Papac-Milicevic N
Front Immunol. 2024; 15:1511886.
PMID: 39635529
PMC: 11614835.
DOI: 10.3389/fimmu.2024.1511886.
Manzo Margiotta F, Michelucci A, Fidanzi C, Granieri G, Salvia G, Bevilacqua M
J Clin Med. 2024; 13(14).
PMID: 39064129
PMC: 11278249.
DOI: 10.3390/jcm13144089.
Vahldieck C, Loning S, Hamacher C, Fels B, Rudzewski B, Nickel L
Front Immunol. 2024; 15:1426526.
PMID: 39055717
PMC: 11269135.
DOI: 10.3389/fimmu.2024.1426526.
Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass.
Banerjee D, Feng J, Sellke F
Front Surg. 2024; 11:1224068.
PMID: 39022594
PMC: 11251955.
DOI: 10.3389/fsurg.2024.1224068.
New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation.
Franco-Acevedo A, Comes J, Mack J, Valenzuela N
Front Transplant. 2024; 2:1146040.
PMID: 38993843
PMC: 11235244.
DOI: 10.3389/frtra.2023.1146040.
Unraveling the Intricate Web: Complement Activation Shapes the Pathogenesis of Sepsis-Induced Coagulopathy.
Wei X, Tu Y, Bu S, Guo G, Wang H, Wang Z
J Innate Immun. 2024; 16(1):337-353.
PMID: 38815564
PMC: 11249610.
DOI: 10.1159/000539502.
The interplay between inflammation and thrombosis in COVID-19: Mechanisms, therapeutic strategies, and challenges.
Ma L, Willey J
Thromb Update. 2024; 8:100117.
PMID: 38620713
PMC: 9270234.
DOI: 10.1016/j.tru.2022.100117.
The role of non-protein-coding RNAs in ischemic acute kidney injury.
Sabet Sarvestani F, Afshari A, Azarpira N
Front Immunol. 2024; 15:1230742.
PMID: 38390339
PMC: 10881863.
DOI: 10.3389/fimmu.2024.1230742.
The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.
Avdonin P, Blinova M, Generalova G, Emirova K, Avdonin P
Biomolecules. 2024; 14(1).
PMID: 38254639
PMC: 10813406.
DOI: 10.3390/biom14010039.
Complement activation products in tears of dry eye and meibomian gland dysfunction.
Maehara H, Norikawa K, Tanaka K, Kato Y, Kasai A, Mukai R
Sci Rep. 2024; 14(1):43.
PMID: 38168536
PMC: 10761822.
DOI: 10.1038/s41598-023-46634-7.
Tear fluid and complement activation products in tears after ocular surgery.
Maehara H, Norikawa K, Tanaka K, Kato Y, Kasai A, Omori T
BMC Ophthalmol. 2023; 23(1):329.
PMID: 37464366
PMC: 10355014.
DOI: 10.1186/s12886-023-03037-6.
Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.
Seidel F, Fluiter K, Kleemann R, Worms N, van Nieuwkoop A, Caspers M
Front Cell Neurosci. 2023; 17:1205261.
PMID: 37457817
PMC: 10346859.
DOI: 10.3389/fncel.2023.1205261.
A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage.
Hatchell D, Alshareef M, Vasas T, Guglietta S, Borucki D, Guo C
J Neuroinflammation. 2023; 20(1):143.
PMID: 37322469
PMC: 10273747.
DOI: 10.1186/s12974-023-02828-4.
A Role for P-selectin and Complement in the Pathological Sequelae of Germinal Matrix Hemorrhage.
Hatchell D, Alshareef M, Vasas T, Guglietta S, Borucki D, Guo C
Res Sq. 2023; .
PMID: 36909595
PMC: 10002788.
DOI: 10.21203/rs.3.rs-2617965/v1.
Venous thromboembolism in viral diseases: A comprehensive literature review.
Zerangian N, Erabi G, Poudineh M, Monajjem K, Diyanati M, Khanlari M
Health Sci Rep. 2023; 6(2):e1085.
PMID: 36778773
PMC: 9900357.
DOI: 10.1002/hsr2.1085.
Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?.
Cauchois R, Muller R, Lagarde M, Dignat-George F, Tellier E, Kaplanski G
J Clin Med. 2023; 12(3).
PMID: 36769407
PMC: 9918301.
DOI: 10.3390/jcm12030758.
Complement System Inhibition Modulates the Inflammation Induced by the Venom of , an Amazon Rainforest Moth Caterpillar.
Gabrili J, Villas-Boas I, Pidde G, Squaiella-Baptistao C, Woodruff T, Tambourgi D
Int J Mol Sci. 2022; 23(21).
PMID: 36362117
PMC: 9658021.
DOI: 10.3390/ijms232113333.
Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1 mouse model.
Verachi P, Gobbo F, Martelli F, Falchi M, Di Virgilio A, Sarli G
Exp Hematol. 2022; 117:43-61.
PMID: 36191885
PMC: 10450205.
DOI: 10.1016/j.exphem.2022.09.004.